On Tuesday, US health officials called for halting the use of the Johnson & Johnson Coronavirus vaccine until further investigation is conducted into cases involving blood clots.
In total, there have been 6 cases where blood clots have been involved after the vaccine is administered. The clots are medically termed as “cerebral venous sinus thrombosis” and are coupled with low blood platelet levels, according to Principle Deputy Director of The CDC, Dr. Anne Schuchat.
Health officials also noted, “Right now, these adverse events appear to be extremely rare.” To date, it’s estimated around 6.8 million doses of the J&J vaccine have been given.
Officials also stated “Until [the investigations] are complete we are recommending a pause in the use of this vaccine out of an abundance of caution. This is important, in part, to ensure that the health care provider community is aware of the potential for these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clot.”
In response to this development, Johnson & Johnson said “We have been working closely with medical experts and health authorities, and we strongly support the open communication of this information to healthcare professionals and the public.”